AbCellera Biologics’s Stock Price And Volume Action

AbCellera Biologics’s ABCL stock has been falling Tuesday, down 5.0% to a price of $38.8. The stock’s volume is currently 372.65 thousand, which is roughly 18.25% of its recent 30-day volume average of 2.04 million.

Why It’s Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: AbCellera Biologics shares are trading higher after the company's 13D showed Peter Thiel reported a 5.3% stake in AbCellera as of December 15th.

Further Analysis of Recent Price Action

The stock’s 50-day moving average was $47.26 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $71.91 and fallen to a low of $38.3.

If you’re looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving’ alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.